EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Xanthatin‐13‐(Pyrrolidine‐2‐Carboxylic Acid), a Sesquiterpene Lactone Isolated From Burdock Leaf, Attenuated Aβ 25‐35 Toxicity and Memory Deficits in a Pharmacological Mouse Model of Alzheimer's Disease

Charlyne Barry-Simonnet iD, Lucie Crouzier iD, Tristan Moujellil-Legagneur iD, Hamza Chaieb-Errass, Yanis A Idres iD, Karine Ferrare iD, Marc Rolland iD, Guillaume Cazals iD, Patrick Poucheret iD, Tangui Maurice iD, Didier Tousch iD

Phytotherapy Research · 2026

DOI: 10.1002/ptr.70294 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytotherapy Research, 2026. Verfasst von Charlyne Barry-Simonnet und 10 weiteren Autor:innen. Beteiligte Einrichtung: MMDN, Univ Montpellier, EPHE, INSERM, Montpellier, France. Hauptthemen laut MEDLINE: Amyloid beta-Peptides, Alzheimer Disease, Memory Disorders, Peptide Fragments. Die Arbeit nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Université de Montpellier.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is a severe form of dementia, which occurrence increases with age and lifestyle conditions. It is characterized by amyloid protein accumulation forming senile plaques, hyperphosphorylated tau protein forming neurofibrillary tangles, neuroinflammation, and oxidative stress, leading to synapse loss and cell death. Pharmacological alternatives to conventional treatments include alkaloids with anti‐inflammatory and antioxidant properties. Sesquiterpene lactones, such as Xanthatin‐13‐(pyrrolidine‐2‐carboxylic acid) (XPc) from burdock leaf, show promise due to their antioxidant activity targeting glucose‐6‐phosphate dehydrogenase. This study evaluated XPc's protective effects in vivo using Aβ 25‐35 ‐treated mice, a pharmacological AD model, and explores its synergistic potential with neuroprotective agents like TSPO activators or sigma‐1 receptor agonists. Mice were administered Aβ 25‐35 peptide (9 nmol ICV) and XPc (0.3–3 mg/kg) daily for 4 days. Behavioral tests assessed memory deficits and anxiety. Post‐sacrifice, brains were analyzed for neuroinflammation and oxidative stress markers. Combination studies involved XPc with the TSPO activator PK11195 or the sigma‐1 receptor agonist PRE‐084, with memory evaluated in two behavioral tests. Combination indices were calculated to assess synergy. XPc (1–3 mg/kg) prevented Aβ 25‐35 ‐induced memory impairments and anxiety. It reduced astroglial reaction, blocked microglial activation, and confirmed antioxidant activity by lowering lipid peroxidation and protein nitrosylation. Combinations with PK11195 or PRE‐084 showed synergistic protection in memory tests. XPc is a potent neuroprotective agent against AD‐like toxicity in this murine model, effective alone or in synergistic combinations with other drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid beta-PeptidesAlzheimer DiseaseMemory DisordersPeptide FragmentsSesquiterpenesLactonesPyrrolidinesAnimalsMiceDisease Models, AnimalMaleNeuroprotective AgentsOxidative StressPlant LeavesReceptors, sigmaSigma-1 ReceptorAntioxidantsBrain

Stichwörter der Autor:innen

anti‐amnesiadrug combinationneuroinflammationneuroprotectionoxidative stresssesquiterpene alkaloid

Substanzen

Amyloid beta-PeptidesPeptide FragmentsSesquiterpenesamyloid beta-protein (25-35)Neuroprotective AgentsReceptors, sigmaLactonesPyrrolidinesSigma-1 ReceptorAntioxidants

Autor:innen und Institutionen

  • MMDN, Univ Montpellier, EPHE, INSERM, Montpellier, France.
  • Qualisud, Univ Montpellier, CIRAD, Institut Agro, Univ Avignon, Univ La Réunion, Montpellier, France.
  • IEM, Univ Montpellier, CNRS, ENSCM, Montpellier, France.
  • PAC Chimie-Balard, Univ Montpellier, CNRS, ENSCM, Montpellier, France.

ORCID-Profile: Charlyne Barry-Simonnet, Lucie Crouzier, Tristan Moujellil-Legagneur, Yanis A Idres, Karine Ferrare, Marc Rolland, Guillaume Cazals, Patrick Poucheret, Tangui Maurice, Didier Tousch

Förderung

  • Université de Montpellier

Zitieren

APA

Barry-Simonnet, C., Crouzier, L., Moujellil-Legagneur, T., Chaieb-Errass, H., Idres, Y. A., Ferrare, K., Rolland, M., Cazals, G., Poucheret, P., Maurice, T., & Tousch, D. (2026). Xanthatin‐13‐(Pyrrolidine‐2‐Carboxylic Acid), a Sesquiterpene Lactone Isolated From Burdock Leaf, Attenuated Aβ 25‐35 Toxicity and Memory Deficits in a Pharmacological Mouse Model of Alzheimer's Disease. Phytotherapy Research. https://doi.org/10.1002/ptr.70294

Vancouver

Barry-Simonnet C, Crouzier L, Moujellil-Legagneur T, Chaieb-Errass H, Idres YA, Ferrare K, et al. Xanthatin‐13‐(Pyrrolidine‐2‐Carboxylic Acid), a Sesquiterpene Lactone Isolated From Burdock Leaf, Attenuated Aβ 25‐35 Toxicity and Memory Deficits in a Pharmacological Mouse Model of Alzheimer's Disease. Phytotherapy Research. 2026. doi:10.1002/ptr.70294

BibTeX
@article{BarrySimonnet2026,
  author = {Barry-Simonnet, Charlyne and Crouzier, Lucie and Moujellil-Legagneur, Tristan and Chaieb-Errass, Hamza and Idres, Yanis A and Ferrare, Karine and Rolland, Marc and Cazals, Guillaume and Poucheret, Patrick and Maurice, Tangui and Tousch, Didier},
  title = {Xanthatin‐13‐(Pyrrolidine‐2‐Carboxylic Acid), a Sesquiterpene Lactone Isolated From Burdock Leaf, Attenuated Aβ 25‐35 Toxicity and Memory Deficits in a Pharmacological Mouse Model of Alzheimer's Disease},
  journal = {Phytotherapy Research},
  year = {2026},
  doi = {10.1002/ptr.70294}
}
Kostenlos starten →